ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Total Current Liabilities
All obligations due within one year.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 759.7% from a year ago
Total current liabilities stood at $70.37M at the end of Q1 FY2026, up 759.7% from a year earlier and up 115.2% from the prior quarter. Over 3 fiscal years it compounded at +156.5% a year.
Context
- Total current liabilities amounted to 12.0% of total assets at the end of Q1 FY2026, up 3.0 pp from a year earlier.
- Total current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +759.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 32.7M USD
- Year-over-year change
- +363.2%
- 4-year CAGR
- +222.2%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.7M | +363.2% |
| FY2024 | 2024-12-31 | 7.06M | +24.4% |
| FY2023 | 2023-12-31 | 5.67M | +193.0% |
| FY2022 | 2022-12-31 | 1.94M | +538.3% |
| FY2021 | 2021-12-31 | 303.35K | — |
Total Current Liabilities vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +759.7% is the highest of 11, against a peer median of -2.5%.
- Total current liabilities amounts to 12.0% of total assets for ASPI, versus a peer median of 16.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$36.46B BRL | +40.8% | +18.5% | 48.6% | |
| Mar 2026 | $895M USD | -6.9% | +2.6% | 14.8% | |
| Mar 2026 | $720.45M USD | -2.6% | -0.2% | 30.9% | |
| Mar 2026 | $532.03M USD | +11.1% | -13.4% | 35.0% | |
| Mar 2026 | $318.03M USD | -2.4% | -18.0% | 20.0% | |
| Mar 2026 | $246.6M USD | -19.8% | +4.5% | 18.1% | |
| Mar 2026 | $70.37M USD | +759.7% | +156.5% | 12.0% | |
| Apr 2026 | $59.92M USD | +3.9% | +12.6% | 14.7% | |
| Mar 2026 | $58.35M USD | -31.9% | +17.3% | 5.0% | |
| Mar 2026 | $40.79M USD | -75.3% | -8.5% | 3.3% | |
| Mar 2026 | $13.37M USD | +183.3% | +66.1% | 9.0% | |
| Peer median (excluding ASPI) | — | -2.5% | +3.5% | 16.4% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.95M | 2.39M | 7.91M | 61.89M | 285.56M |
| Short-term Investments | 0 | 0 | 0 | 0 | 47.75M |
| Net Receivables | 0 | 0 | 938.05K | 734.48K | 51.71M |
| Inventory | 0 | 0 | 0 | 65.66K | 8.49M |
| Other Current Assets | 0 | 913.01K | 1.66M | 3.05M | 2.64M |
| Total Current Assets | 3.22M | 3.3M | 10.51M | 65.74M | 398.14M |
| Property, Plant & Equipment (Net) | 3.92M | 9.05M | 11.97M | 23.48M | 34.96M |
| Goodwill | 0 | 0 | 3.27M | 3.17M | 8.57M |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.48M |
| Long-term Investments | 0 | 0 | 0 | 0 | 49M |
| Tax Assets | 0 | 0 | 0 | 5.77M | 14.86M |
| Other Non-current Assets | (1) | 139.64K | 4.44M | (3.81M) | 5.87M |
| Total Non-current Assets | 3.92M | 9.19M | 19.68M | 28.6M | 114.74M |
| Total Assets | 7.14M | 12.5M | 30.19M | 94.35M | 512.88M |
| Account Payables | 59.68K | 1.35M | 1.11M | 1.02M | 5.76M |
| Short-term Debt | 46.9K | 33.85K | 470.4K | 939.11K | 13.64M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 882K | 882K | 882K |
| Other Current Liabilities | 116.2K | 140.46K | 1.97M | 1.26M | 8.84M |
| Total Current Liabilities | 303.35K | 1.94M | 5.67M | 7.06M | 32.7M |
| Long-term Debt | 0 | 0 | 0 | 34.87M | 200.79M |
| Deferred Tax Liabilities | 0 | 0 | 110.58K | 0 | 14.96M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 4.3M | 5.74M | 0 |
| Total Non-current Liabilities | 841.62K | 742.44K | 5.68M | 41.87M | 217.29M |
| Total Liabilities | 1.14M | 2.68M | 11.36M | 43.18M | 249.98M |
| Common Stock | 206.53K | 359.07K | 489.23K | 720.68K | 1.12M |
| Retained Earnings | (2.61M) | (7.55M) | (23.84M) | (56.17M) | (231.27M) |
| Accumulated OCI | 18.72K | 255.03K | (920.98K) | (2.16M) | 2.54M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 2.53M | 3.27M | 58.75M |
| Total Equity | 6M | 9.82M | 18.83M | 51.17M | 262.9M |
| Total Debt | 926.6K | 822.2K | 2.14M | 37.75M | 215.96M |
| Net Debt | (2.03M) | (1.57M) | (5.77M) | (24.14M) | (69.6M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.